Concepedia

Antonio Llinàs

AL

30

Publications

2K

Citations

21

H-Index

1998

Active since

Affiliations

AstraZeneca (Sweden)(Current)

University of Cambridge

University of Huddersfield

Unilever (United Kingdom)

Pfizer (United Kingdom)

Antonio Llinàs is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1998–2023

30

Publications

30

Oxadiazoles in Medicinal Chemistry

Jonas Boström, Anders Hogner, Antonio Llinàs et al. · Journal of Medicinal Chemistry · 2011 · 579 citations · Full text

, , +13

Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements?

Antonio Llinàs, Robert C. Glen, Jonathan M. Goodman · Journal of Chemical Information and Modeling · 2008 · 203 citations

Diclofenac Solubility:  Independent Determination of the Intrinsic Solubility of Three Crystal Forms

Antonio Llinàs, J. Burley, Karl Box et al. · Journal of Medicinal Chemistry · 2007 · 131 citations

, , +22

Predicting Intrinsic Aqueous Solubility by a Thermodynamic Cycle

David Scott Palmer, Antonio Llinàs, Iñaki Morao et al. · Molecular Pharmaceutics · 2008 · 129 citations

Beyond Size, Ionization State, and Lipophilicity: Influence of Molecular Topology on Absorption, Distribution, Metabolism, Excretion, and Toxicity for Druglike Compounds

Yidong Yang, Ola Engkvist, Antonio Llinàs et al. · Journal of Medicinal Chemistry · 2012 · 129 citations

Rows per page

1–5 of 30